Latest podcast episode – Tailoring drug therapy to your genes

Research / 03 August 2021

Photo: iStock

Drug Safety Matters dives into the fascinating field of pharmacogenomics and the implications it has for tailored treatments and safer prescribing practices.


Genetic variation is one of the reasons people differ in their response to medicines. Understanding that variation can inform more refined choices of drugs and doses – ultimately preventing undesired side effects. Join us as we discuss past, present and future of pharmacogenomics with Uppsala Monitoring Centre’s Qun-Ying Yue.

 

Subscribe by visiting the Drug Safety Matters website or listen in right here:

 

Read more

Pharmacogenomics group aims to refine patient safety options

Africa integral to evolution of pharmacogenomics research

You may also like


The colour of signals

Herbal remedies have been used for thousands of years to treat what ails us. Yet why do we still know so little about their potential side effects compared to modern medicines?

Research / 29 August 2023

Digging deeper into Montelukast and nightmares

There is much to be gained from using VigiBase to further explore known adverse reactions to drugs, as some may be having more of an impact on patients than first thought.

Research / 18 September 2023

Assessing safety in clinical trials - New podcast out now

Medicine safety monitoring applies to all aspects of drug development, but how much is it impacted by patient diversity and study type in clinical trials?

Research / 29 June 2023

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more